MultiCell Technologies Inc. (MUCL) Licensee Markets Immortalized Cell Lines At American Association of Pharmaceutical Scientists
10/19/2005 5:09:02 PM
MultiCell Technologies, Inc. (OTCBB:MUCL), leading supplier of functional non-tumorigenic immortalized human hepatocyte lines Fa2n-4 and EA1C-35, announced that XenoTech LLC, its marketing and manufacturing licensee, presented MultiCell's cells at the American Association of Pharmaceutical Scientists meeting November 7th - 11th in Baltimore, MD. This year's annual meeting was the highest-attended AAPS event ever, with over 4,500 registrations and over 450 exhibitors.
comments powered by